An update on methods for cryopreservation and thawing of hemopoietic stem cells

Lucilla Lecchi, Silvia Giovanelli, Barbara Gagliardi, Ilaria Pezzali, Ilaria Ratti, Maurizio Marconi

Research output: Contribution to journalReview article

14 Citations (Scopus)

Abstract

The aim of this article is to review a number of variables that may affect the cryopreservation of minimally manipulated products containing allogeneic or autologous hemopoietic progenitor cells (HPC) used for transplantation, with particular reference to processing, type and addition of cryoprotectant, cell concentration, volume, freezing procedure, cooling rate, storage, thawing, and quality management. After defining final product's requirements in compliance with norms, laws and regulations, it is crucial to define the critical control points of the process.New approaches of processing were developed in the last few years such as automatic devices for volume reduction and high cell concentration in the frozen product. DMSO at 10% final concentration is still the most used cryoprotectant for HPC cryopreservation. Although controlled rate freezing is the recommended method for HPC cryopreservation, alternative methods may be used. Last generation vapor storage vessels ensure temperature stability better than older tanks. Their use may reduce risks of cross-contamination.Finally we review advantages and disadvantages of thawing procedures that may be carried out in the laboratory or at the patient's bedside.

Original languageEnglish
Pages (from-to)324-336
Number of pages13
JournalTransfusion and Apheresis Science
Volume54
Issue number3
DOIs
Publication statusPublished - Jun 1 2016

Fingerprint

Cryopreservation
Stem Cells
Freezing
Cell Transplantation
Dimethyl Sulfoxide
Cell Size
Equipment and Supplies
Temperature

Keywords

  • Cryopreservation
  • Hemopoietic stem cells
  • Thawing

ASJC Scopus subject areas

  • Hematology

Cite this

An update on methods for cryopreservation and thawing of hemopoietic stem cells. / Lecchi, Lucilla; Giovanelli, Silvia; Gagliardi, Barbara; Pezzali, Ilaria; Ratti, Ilaria; Marconi, Maurizio.

In: Transfusion and Apheresis Science, Vol. 54, No. 3, 01.06.2016, p. 324-336.

Research output: Contribution to journalReview article

Lecchi, Lucilla ; Giovanelli, Silvia ; Gagliardi, Barbara ; Pezzali, Ilaria ; Ratti, Ilaria ; Marconi, Maurizio. / An update on methods for cryopreservation and thawing of hemopoietic stem cells. In: Transfusion and Apheresis Science. 2016 ; Vol. 54, No. 3. pp. 324-336.
@article{545a81ac36ad4716ad2d7a4f009c8b60,
title = "An update on methods for cryopreservation and thawing of hemopoietic stem cells",
abstract = "The aim of this article is to review a number of variables that may affect the cryopreservation of minimally manipulated products containing allogeneic or autologous hemopoietic progenitor cells (HPC) used for transplantation, with particular reference to processing, type and addition of cryoprotectant, cell concentration, volume, freezing procedure, cooling rate, storage, thawing, and quality management. After defining final product's requirements in compliance with norms, laws and regulations, it is crucial to define the critical control points of the process.New approaches of processing were developed in the last few years such as automatic devices for volume reduction and high cell concentration in the frozen product. DMSO at 10{\%} final concentration is still the most used cryoprotectant for HPC cryopreservation. Although controlled rate freezing is the recommended method for HPC cryopreservation, alternative methods may be used. Last generation vapor storage vessels ensure temperature stability better than older tanks. Their use may reduce risks of cross-contamination.Finally we review advantages and disadvantages of thawing procedures that may be carried out in the laboratory or at the patient's bedside.",
keywords = "Cryopreservation, Hemopoietic stem cells, Thawing",
author = "Lucilla Lecchi and Silvia Giovanelli and Barbara Gagliardi and Ilaria Pezzali and Ilaria Ratti and Maurizio Marconi",
year = "2016",
month = "6",
day = "1",
doi = "10.1016/j.transci.2016.05.009",
language = "English",
volume = "54",
pages = "324--336",
journal = "Transfusion and Apheresis Science",
issn = "1473-0502",
publisher = "Elsevier Limited",
number = "3",

}

TY - JOUR

T1 - An update on methods for cryopreservation and thawing of hemopoietic stem cells

AU - Lecchi, Lucilla

AU - Giovanelli, Silvia

AU - Gagliardi, Barbara

AU - Pezzali, Ilaria

AU - Ratti, Ilaria

AU - Marconi, Maurizio

PY - 2016/6/1

Y1 - 2016/6/1

N2 - The aim of this article is to review a number of variables that may affect the cryopreservation of minimally manipulated products containing allogeneic or autologous hemopoietic progenitor cells (HPC) used for transplantation, with particular reference to processing, type and addition of cryoprotectant, cell concentration, volume, freezing procedure, cooling rate, storage, thawing, and quality management. After defining final product's requirements in compliance with norms, laws and regulations, it is crucial to define the critical control points of the process.New approaches of processing were developed in the last few years such as automatic devices for volume reduction and high cell concentration in the frozen product. DMSO at 10% final concentration is still the most used cryoprotectant for HPC cryopreservation. Although controlled rate freezing is the recommended method for HPC cryopreservation, alternative methods may be used. Last generation vapor storage vessels ensure temperature stability better than older tanks. Their use may reduce risks of cross-contamination.Finally we review advantages and disadvantages of thawing procedures that may be carried out in the laboratory or at the patient's bedside.

AB - The aim of this article is to review a number of variables that may affect the cryopreservation of minimally manipulated products containing allogeneic or autologous hemopoietic progenitor cells (HPC) used for transplantation, with particular reference to processing, type and addition of cryoprotectant, cell concentration, volume, freezing procedure, cooling rate, storage, thawing, and quality management. After defining final product's requirements in compliance with norms, laws and regulations, it is crucial to define the critical control points of the process.New approaches of processing were developed in the last few years such as automatic devices for volume reduction and high cell concentration in the frozen product. DMSO at 10% final concentration is still the most used cryoprotectant for HPC cryopreservation. Although controlled rate freezing is the recommended method for HPC cryopreservation, alternative methods may be used. Last generation vapor storage vessels ensure temperature stability better than older tanks. Their use may reduce risks of cross-contamination.Finally we review advantages and disadvantages of thawing procedures that may be carried out in the laboratory or at the patient's bedside.

KW - Cryopreservation

KW - Hemopoietic stem cells

KW - Thawing

UR - http://www.scopus.com/inward/record.url?scp=84971372987&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84971372987&partnerID=8YFLogxK

U2 - 10.1016/j.transci.2016.05.009

DO - 10.1016/j.transci.2016.05.009

M3 - Review article

VL - 54

SP - 324

EP - 336

JO - Transfusion and Apheresis Science

JF - Transfusion and Apheresis Science

SN - 1473-0502

IS - 3

ER -